1 Market Overview
    1.1 KRAS G12C Inhibitors Definition
    1.2 Global KRAS G12C Inhibitors Market Size and Forecast
        1.2.1 By Consumption Value, Global KRAS G12C Inhibitors Market Size, 2020-2031
        1.2.2 By Sales Quantity, Global KRAS G12C Inhibitors Market Size, 2020-2031
        1.2.3 Global KRAS G12C Inhibitors Average Selling Price (ASP), 2020-2031
    1.3 China KRAS G12C Inhibitors Market Size and Forecast
        1.3.1 By Consumption Value, China KRAS G12C Inhibitors Market Size, 2020-2031
        1.3.2 By Sales Quantity, China KRAS G12C Inhibitors Market Size, 2020-2031
        1.3.3 China KRAS G12C Inhibitors Average Selling Price (ASP), 2020-2031
    1.4 Share of China KRAS G12C Inhibitors Market with Respect to the Global Market
        1.4.1 By Consumption Value, China KRAS G12C Inhibitors Market Share in Global, 2020-2031
        1.4.2 By Sales Quantity, China KRAS G12C Inhibitors Market Share in Global, 2020-2031
        1.4.3 KRAS G12C Inhibitors Market Size: China VS Global, 2020-2031
    1.5 KRAS G12C Inhibitors Market Dynamics
        1.5.1 KRAS G12C Inhibitors Market Drivers
        1.5.2 KRAS G12C Inhibitors Market Restraints
        1.5.3 KRAS G12C Inhibitors Industry Trends
        1.5.4 KRAS G12C Inhibitors Industry Policy
2 Global Leading Manufacturers and Market Share
    2.1 By Revenue of KRAS G12C Inhibitors, Global Market Share by Company, 2020-2025
    2.2 By Sales Quantity of KRAS G12C Inhibitors, Global Market Share by Company, 2020-2025
    2.3 KRAS G12C Inhibitors Average Selling Price (ASP) by Company, 2020-2025
    2.4 Global KRAS G12C Inhibitors Participants, Market Position (Tier 1, Tier 2, and Tier 3)
    2.5 Global KRAS G12C Inhibitors Concentration Ratio
    2.6 Global KRAS G12C Inhibitors Mergers & Acquisitions, Expansion Plans
    2.7 Global KRAS G12C Inhibitors Manufacturers Product Type
    2.8 Head Office and KRAS G12C Inhibitors Production Site of Key Manufacturer
    2.9 KRAS G12C Inhibitors Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
    3.1 By Revenue of KRAS G12C Inhibitors, China Market Share by Company, 2020-2025
    3.2 By Sales Quantity of KRAS G12C Inhibitors, China Market Share by Company, 2020-2025
    3.3 China KRAS G12C Inhibitors KRAS G12C Inhibitors Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
    4.1 Global KRAS G12C Inhibitors Capacity, Output and Capacity Utilization, 2020-2031
    4.2 Global KRAS G12C Inhibitors Capacity by Region
    4.3 Global KRAS G12C Inhibitors Production & Forecast by Region, 2020 VS 2024 VS 2031
    4.4 Global KRAS G12C Inhibitors Production by Region, 2020-2031
    4.5 Global KRAS G12C Inhibitors Production Market Share & Forecast by Region, 2020-2031
5 Industry Chain Analysis
    5.1 KRAS G12C Inhibitors Industry Chain
    5.2 KRAS G12C Inhibitors Upstream Analysis
        5.2.1 KRAS G12C Inhibitors Core Raw Materials
        5.2.2 Main Manufacturers of KRAS G12C Inhibitors Core Raw Materials
    5.3 Midstream Analysis
    5.4 Downstream Analysis
    5.5 KRAS G12C Inhibitors Production Mode
    5.6 KRAS G12C Inhibitors Procurement Model
    5.7 KRAS G12C Inhibitors Industry Sales Model and Sales Channels
        5.7.1 KRAS G12C Inhibitors Sales Model
        5.7.2 KRAS G12C Inhibitors Typical Distributors
6 Sights by Product Type
    6.1 KRAS G12C Inhibitors Classification
        6.1.1 Garsorasib
        6.1.2 Fulzerasib
        6.1.3 Adagrasib
        6.1.4 Sotorasib
    6.2 by Type, Global KRAS G12C Inhibitors Consumption Value & CAGR, 2020 VS 2024 VS 2031
    6.3 by Type, Global KRAS G12C Inhibitors Consumption Value, 2020-2031
    6.4 by Type, Global KRAS G12C Inhibitors Sales Quantity, 2020-2031
    6.5 by Type, Global KRAS G12C Inhibitors Average Selling Price (ASP), 2020-2031
7 Sights by Application
    7.1 KRAS G12C Inhibitors Segment by Application
        7.1.1 Hospital
        7.1.2 Clinic
        7.1.3 Others
    7.2 by Application, Global KRAS G12C Inhibitors Consumption Value & CAGR, 2020 VS 2024 VS 2031
    7.3 by Application, Global KRAS G12C Inhibitors Consumption Value, 2020-2031
    7.4 by Application, Global KRAS G12C Inhibitors Sales Quantity, 2020-2031
    7.5 by Application, Global KRAS G12C Inhibitors Price, 2020-2031
8 Sales Sights by Region
    8.1 By Region, Global KRAS G12C Inhibitors Consumption Value, 2020 VS 2024 VS 2031
    8.2 By Region, Global KRAS G12C Inhibitors Consumption Value, 2020-2031
    8.3 By Region, Global KRAS G12C Inhibitors Sales Quantity, 2020-2031
    8.4 North America
        8.4.1 North America KRAS G12C Inhibitors Market Size & Forecasts, 2020-2031
        8.4.2 By Country, North America KRAS G12C Inhibitors Market Size Market Share
    8.5 Europe
        8.5.1 Europe KRAS G12C Inhibitors Market Size & Forecasts, 2020-2031
        8.5.2 By Country, Europe KRAS G12C Inhibitors Market Size Market Share
    8.6 Asia Pacific
        8.6.1 Asia Pacific KRAS G12C Inhibitors Market Size & Forecasts, 2020-2031
        8.6.2 By Country/Region, Asia Pacific KRAS G12C Inhibitors Market Size Market Share
    8.7 South America
        8.7.1 South America KRAS G12C Inhibitors Market Size & Forecasts, 2020-2031
        8.7.2 By Country, South America KRAS G12C Inhibitors Market Size Market Share
    8.8 Middle East & Africa
9 Sales Sights by Country Level
    9.1 By Country, Global KRAS G12C Inhibitors Market Size & CAGR, 2020 VS 2024 VS 2031
    9.2 By Country, Global KRAS G12C Inhibitors Consumption Value, 2020-2031
    9.3 By Country, Global KRAS G12C Inhibitors Sales Quantity, 2020-2031
    9.4 United States
        9.4.1 United States KRAS G12C Inhibitors Market Size, 2020-2031
        9.4.2 by Type, United States KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
        9.4.3 by Application, United States KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
    9.5 Europe
        9.5.1 Europe KRAS G12C Inhibitors Market Size, 2020-2031
        9.5.2 by Type, Europe KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
        9.5.3 by Application, Europe KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
    9.6 China
        9.6.1 China KRAS G12C Inhibitors Market Size, 2020-2031
        9.6.2 by Type, China KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
        9.6.3 by Application, China KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
    9.7 Japan
        9.7.1 Japan KRAS G12C Inhibitors Market Size, 2020-2031
        9.7.2 by Type, Japan KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
        9.7.3 by Application, Japan KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
    9.8 South Korea
        9.8.1 South Korea KRAS G12C Inhibitors Market Size, 2020-2031
        9.8.2 by Type, South Korea KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
        9.8.3 by Application, South Korea KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
    9.9 Southeast Asia
        9.9.1 Southeast Asia KRAS G12C Inhibitors Market Size, 2020-2031
        9.9.2 by Type, Southeast Asia KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
        9.9.3 by Application, Southeast Asia KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
    9.10 India
        9.10.1 India KRAS G12C Inhibitors Market Size, 2020-2031
        9.10.2 by Type, India KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
        9.10.3 by Application, India KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
    9.11 Middle East & Africa
        9.11.1 Middle East & Africa KRAS G12C Inhibitors Market Size, 2020-2031
        9.11.2 by Type, Middle East & Africa KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
        9.11.3 by Application, Middle East & Africa KRAS G12C Inhibitors Sales Quantity Market Share, 2024 VS 2031
10 Manufacturers Profile
    10.1 Amgen
        10.1.1 Amgen Company Information, Head Office, Market Area, and Industry Position
        10.1.2 Amgen KRAS G12C Inhibitors Models, Specifications, and Application
        10.1.3 Amgen KRAS G12C Inhibitors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
        10.1.4 Amgen Company Profile and Main Business
        10.1.5 Amgen Recent Developments
    10.2 Innovent Biologics, Inc.
        10.2.1 Innovent Biologics, Inc. Company Information, Head Office, Market Area, and Industry Position
        10.2.2 Innovent Biologics, Inc. KRAS G12C Inhibitors Models, Specifications, and Application
        10.2.3 Innovent Biologics, Inc. KRAS G12C Inhibitors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
        10.2.4 Innovent Biologics, Inc. Company Profile and Main Business
        10.2.5 Innovent Biologics, Inc. Recent Developments
    10.3 Mirati Therapeutics
        10.3.1 Mirati Therapeutics Company Information, Head Office, Market Area, and Industry Position
        10.3.2 Mirati Therapeutics KRAS G12C Inhibitors Models, Specifications, and Application
        10.3.3 Mirati Therapeutics KRAS G12C Inhibitors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
        10.3.4 Mirati Therapeutics Company Profile and Main Business
        10.3.5 Mirati Therapeutics Recent Developments
    10.4 Genfleet Therapeutics (Shanghai), Inc.
        10.4.1 Genfleet Therapeutics (Shanghai), Inc. Company Information, Head Office, Market Area, and Industry Position
        10.4.2 Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Models, Specifications, and Application
        10.4.3 Genfleet Therapeutics (Shanghai), Inc. KRAS G12C Inhibitors Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
        10.4.4 Genfleet Therapeutics (Shanghai), Inc. Company Profile and Main Business
        10.4.5 Genfleet Therapeutics (Shanghai), Inc. Recent Developments
11 Conclusion
12 Appendix
    12.1 Research Methodology
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Market Estimation Model
    12.4 Disclaimer